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W ith the nation’s stated goal of  producing 35 billion gallons of  renewable fuels by the year 
2017, there are concerns as to whether 
there will be enough corn to fuel the 
burgeoning ethanol industry, as well as 
supply the needs of  the livestock  
producers and food industries.
Ethanol from crop waste, grass or other 
materials—known as biomass—may 
hold the key to helping the United States 
reduce its reliance on petroleum. And in 
Emmetsburg, Iowa, the nation’s largest 
dry-mill ethanol producer is constructing 
the world’s first commercial-sized  
cellulosic ethanol plant in hopes of   
unlocking the secrets to producing  
ethanol from biomass.
Jeff  Broin, chief  executive of  Broin  
Companies, says his company will  
convert its Voyager Ethanol plant in  
Emmetsburg from a 50 million-gal-
lon-a-year conventional corn dry-mill 
facility into a 125 million-gallon-a-year 
commercial-scale biorefinery producing 
ethanol from not only corn but from corn 
stover—the stalk, leaves and cobs of  the 
corn plant.
“This is an important initiative for both 
the Broin Companies and the ethanol 
industry,” Broin says of  the project that 
is receiving an $80-million U.S. Depart-
ment of  Energy grant. “The need to 
commercialize cellulosic ethanol is ap-
parent as the United States continues to 
move away from its dependence on fossil 
fuels. We have been working very hard 
at developing technologies and making 
advancements the past several years to 
position Broin as a leader in this area. 
The project in Emmetsburg is a major 
step toward reaching that goal.”
Known as Project Liberty, the $200- 
million expansion has an expected 
completion date in mid-2009, says  
Mike Muston, Project Liberty manager. 
“Project Liberty will create commercial-
ization results that include 27 percent 
more ethanol from an acre of  corn while 
using 83 percent less fossil fuels needed 
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Tate & Lyle’s $260 million  
Iowa investment 
B ringing new proprietary technologies to Iowa, Tate & Lyle has begun construction of  a $260 million industrial starch and ethanol plant near Fort Dodge, the first corn wet mill to be built in the United States in more than a decade.
When completed in spring 2009, the Tate & Lyle facility will create 
110 new full-time jobs. The huge facility will process 150,000 bushels 
of  corn a day, producing more than 100 million gallons of  ethanol 
per year.
Chris Olsen, director of  community and governmental relations for 
Tate & Lyle, says the London-based company is an industry leader in 
cereal sweeteners and starches, sugar refining, value-added food and 
industrial ingredients.
Olsen says the corn wet milling facility will employ state-of-the-art 
technologies that make processing corn more efficient and will lower 
the costs of  a variety of  products.
As corporate officials gathered for the official ground breaking cer-
emony last fall, Tate & Lyle CEO Iain Ferguson said “this marks the 
beginning of  a bright future for both the company and Fort Dodge  
as we move closer to our main ingredient."
“This investment will double our ethanol capacity, producing  
environmental and energy-saving benefits in the U.S. while  
reducing America’s foreign oil dependence,” he continued. “This  
is an important strategic move into the western Corn Belt.”
Along with ethanol, the facility will produce cationic starches for the 
paper industry. “Cationic starches are used to improve the internal 
bond and tensile strength during the paper-making process,” says 
Olsen.
While Tate & Lyle looked at sites throughout the western Corn Belt, 
Olsen said Fort Dodge was selected “due to its local corn supplies, 
two railroads, available and skilled workforce and cooperation from 
local and state officials.”
Leveraging the plant—the single largest business investment in Web-
ster County’s history, according to John Kramer, executive director 
of  Webster County Economic Development—was a series of  awards 
from Iowa Department of  Economic Development programs.
Those include a $1 million award from the Community Economic 
Betterment Account (CEBA), and $300,000 from the Value-Added 
Agricultural Products and Processes Financial Assistance Program 
(VAAPFAP), along with tax incentives and road improvements from 
Webster County.
 “Tate & Lyle believes the corn fields of  today will be the oil fields  
of  the future. So what better place to build but here in Iowa?”  
says Ferguson.   ■
“Supported by strong investment in  
R&D and new manufacturing plants  
like Fort Dodge, our scientists are  
working hard to meet demands for  
renewable energy and move towards  
an ever more bio-based economy.  
We’re very proud to be building here  
in Iowa and very much look forward to 
becoming part of the local community.”
Iain Ferguson 
Chief Executive 
Tate & Lyle
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 Embria Health Sciences to build $12 million 
headquarters in Iowa
Embria® Health Sciences, manufacturer 
of  natural ingredients for use in high-
quality human nutritional products, is 
in the midst of  building a $12-million 
headquarters facility in the central Iowa 
community of  Ankeny. The 5.1-acre site 
will include manufacturing facilities for 
its two new human nutrition ingredients: 
EpiCor® and eXselen®.
With the successful international launch 
of  those two natural ingredients to the 
human-nutrition market, Embria will 
use its new Iowa headquarters to look 
for continued opportunities to design 
products and ingredients that assist the 
immune system and further human 
health says Paul Faganel, Embria Health 
Sciences president. 
Both ingredients are backed by 15  
years of  research and by 60 years of  
proprietary fermentation technology 
by Embria’s parent company, Diamond 
V® Mills, which began researching 
and developing nutritional products in 
1943. Since then, the company has been  
recognized as a global leader in animal 
nutrition. 
“Our proprietary fermentation and 
drying technology produces biologically 
complex products. The end result of  our 
process is unique metabolites that provide 
beneficial nourishment and superior 
bioavailability to our ingredients,” says 
Faganel.
Those who know the human nutrition 
market agree. Embria holds Nutrition 
Business Journal’s 2005 product merit 
award for its launch of  eXselen®, and 
Embria was named one of  Nutraceuticals 
World’s 2006 “Companies to Watch.” 
In early 2007, Embria was honored with 
Nutrition Business Journal’s Investment 
in the Future Award for its substantial 
2006 internal growth, long-term invest-
ments and flagship ingredient, EpiCor®.
“eXselen® is an all-natural, organic 
ingredient that guarantees high levels of  
organic selenium, an essential trace min-
eral the human body is dependent on but 
can’t produce on its own,” says Faganel. 
“EpiCor® is an all-natural, high-metabo-
lite immunogen that helps support and 
balance a healthy immune system.”
 
Embria chose Ankeny for its headquar-
ters after conducting a national site- 
selection search. “After a thorough 
research of  several states’ tax rates, 
regulations and overall business climate, 
we came back to Iowa as the place to do 
business,” says Faganel. “We’re confident 
our commitment to Iowa will enhance 
and build upon the state’s already strong 
economic pulse.”
The expansion project was awarded 
$140,000 from the Community Econom-
ic Betterment Account (CEBA) and tax 
benefits from High Quality Jobs Creation 
(HQJC) program, both administered 
by the Iowa Department of  Economic 
Development. When the project is  
completed in mid-2007, 28 new jobs  
will be created with 16 of  the jobs paying 
an average wage of  $59.23 per hour. 
Combining science with nature to  
deliver high-quality, research-based 
natural ingredients to the global human 
nutrition market, Embria will continue to 
design condition-specific ingredients and 
supplements that bolster human health. 
And just as Embria’s natural ingredients 
can help keep people healthy, Embria has 
found that an Iowa location bolsters its 
bottom line.   ■
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On the campus of  the University of  Iowa, a new biobank facility—the world’s largest and the third of  its kind—will soon be advancing  development of  customized medicine for  
skin cancers and other related skin conditions.
National Genecular Institute, Inc. (NGI), a fully owned  
research subsidiary of  Newport Beach, Calif.-based  
Dermacia, is constructing not only the biobank — known as 
the BioTrust™ — but also locating its pharmacogenomic and 
cosmeceuticals research and development operation in the 
Oakdale Research Park.
In fact, Dr. Tannin Fuja, NGI chief  scientific officer, says the 
company has begun the process of  hiring 178 new employees 
while taking up temporary residence on the University of  
Iowa Oakdale campus.
Fuja said the company is beginning to hire employees across  
a wide range of  levels and disciplines including engineers,  
IT specialists, biologists and chemists as well as research  
assistants, lab technicians and office staff. “Employees are  
being recruited nationally and are relocating to Iowa,” says 
Fuja. “However we plan to draw significantly from the  
available and highly skilled Iowa labor pool.”
Dermacia is known as the industry leader in the development 
of  cosmeceuticals—skin care products formulated to provide 
cosmetic and  therapeutic benefits to the user. Its Lycogel™ 
and Dermesse™ product lines are designed for post-plastic 
surgery cover and special camouflage applications, facilitat-
ing rapid healing of  wounds and minimization of  scarring 
while providing effective, flawless cover. “Our products are 
sold in more than 1,000 physicians’ offices as well as surgical 
and dermatology centers and pharmacies across the U.S. and 
Mexico,” says Fuja. 
Fuja explains that the biobank at UI’s Oakdale Research Park 
will be a depository of  genetic and cellular materials which 
are linked to updated medical history of  donors. “Biobank-
ing remains the most efficient and effective means to helping 
researchers move closer to the development of  customized 
medicines for complex, rare and often mistreated diseases,” 
says Fuja.
The $26-million expansion, which includes a new 90,000 
square foot research facility and 20,000 square foot bio-
bank, was awarded $655,000 from the Iowa Department of  
Economic Development-administered Community Economic  
Betterment Account (CEBA) as well as tax benefits from the 
High Quality Jobs Creation (HQJC) program.
   
“We’ll use our research and development from our new Iowa 
location to fuel our rapid sales growth and aggressive market-
ing and product initiatives, including research and develop-
ment of  nanotechnology and genetic science applications in 
cosmetics and skin care,” says Matt Nicosia, Dermacia’s chief  
executive officer and co-founder.    ■
Cosmeceutical company Dermacia to build biobank,  
R & D facilities in Iowa
5 Iowa’s Tjaden Biosciences poised to 
meet worldwide opportunities
Recent start-up Tjaden Biosciences came about through the vision of  Erik Tjaden who returned to his hometown of  Burlington, Iowa,  
to launch the venture. The company,  
located in 13,000 square feet of  office  
and laboratory space, began filling its  
first orders in January 2007.
While working at a lab that offered a diverse 
array of  pharmaceutical services including 
custom radiosynthesis, Tjaden saw an  
opportunity for a new radiochemical 
company manufacturing and distributing 
custom and catalogue compounds radio-
labeled with carbon-14 and tritium,  “The 
$200-million-a-year industry is evolving and 
changing,” says Tjaden. “Large pharma-
ceutical and life sciences companies are 
reducing in-house capabilities in favor of  
increased outsourcing to reduce operational 
costs, while smaller biotech companies rely 
completely on the outsourcing model.”
Tjaden Biosciences “implants radioactive 
isotopes into molecules, allowing research-
ers to study how compounds interact with 
blood and tissue, and the environment,” 
explains Tjaden, adding that a sheet of   
paper provides enough protection to block 
the radiation emitted by carbon–14 and  
tritium. “The radioactive molecules, 
which are used  to track how the com-
pounds breakdown in the body and are 
eliminated, are used in early phases of  
research, as well as in animal and human 
drug trials.”
Custom synthesis compounds will be made 
to meet a client company’s specifications, 
while catalogue items are more basic: 
components that will be made and stored 
on-site and bought off  the shelf  by custom-
ers. “Our catalogue inventory includes bulk 
synthetic intermediate that researchers 
subsequently convert into more complex 
proprietary molecules and biologically 
relevant compounds such as steroids, carbo-
hydrates, amino and fatty acids and others 
that are used directly in academic research,” 
says Tjaden.
Not only does Tjaden manufacture and 
distribute commonly used or catalogue 
radiochemical compounds, they also 
custom make radio labeled compounds for 
customers. “Our tailor-made radio chemi-
cal compounds are used in pharmaceuti-
cal, agrichemical, and consumer-product 
research and development departments,” 
says Tjaden.
The 6,800 square feet of  office space and 
7,500 square feet of  warehouse space is 
more than the startup needs at the moment. 
“It will give us ample room to grow,” says 
Tjaden, whose partner in the company is 
Russian chemist Andrey Topin. 
The start-up company was awarded 
$40,000 from the Community Economic 
Betterment Account (CEBA), administered 
by the Iowa Department of  Economic 
Development. In return, Tjaden pledged to 
create eight jobs paying an average wage of  
$32.09 per hour. There are currently three 
employees on staff, including Phil Korb, a 
synthetic chemist who has more than 40 
years of  experience.
“Our goal is to be the premier supplier 
of  radiochemical products and services 
to the life sciences industry,” says Tjaden. 
“Our business model is to provide high 
quality radiochemicals in a timely fashion 
and reasonable price while being environ-
mentally responsible. We are committed to 
understanding, meeting and exceeding our 
customers’ requirements.”   ■
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            Project Liberty — Continued from page 1
Researching disease  
treatment & detection 
VIDA Diagnostics, a company located in the University of  Iowa’s  
Technology Innovation Center, has earned a $750,000, two-year grant 
from the National Institutes of  Health to advance an imaging system that 
can detect and treat lung diseases including lung cancer and emphysema. 
VIDA received a Phase II Small Business Innovation Research (SBIR) 
grant, a highly competitive funding program used by federal agencies to 
fund small business research and development. VIDA Diagnostics is a  
spin-off  company using core technology licensed from the university.  
Earlier, VIDA Diagnostics was awarded $100,000 from the Iowa  
Department of  Economic Development for product development.
Gap funding from the Iowa Values Fund has been awarded by the  
University of  Iowa to an early stage technology under development by 
Gregory Leno and John Engelhardt, professors in the department of   
anatomy and cell biology. The research will develop cell therapy  
techniques that could be used to treat Alzheimer’s Disease, Parkinson’s 
Disease and other diseases. A startup company, RepGenix LLC, is being 
formed around their discoveries, in collaboration with other Iowa  
resources and companies.   ■
to ferment corn into ethanol and 
reducing water consumption at an 
ethanol plant by 24 percent.
Broin, which operates 19 ethanol 
plants throughout the U.S., could 
have located Project Liberty at any 
of  its existing plants. “Emmetsburg 
was chosen because of  its access 
to main rail lines, abundant water 
resources, and a good location in 
a major corn-producing region,” 
notes Muston. “Local and state 
governmental leaders have been 
very supportive and the state’s  
permitting process is streamlined.”
The expansion project will receive 
a series of  tax abatements and 
credits from the Iowa Department 
of  Economic Development-admin-
istered Enterprise Zone program.
While there are still challenges to 
overcome in making cellulosic  
ethanol, “We are partnering with 
Iowa State University, DuPont,  
ag-equipment manufacturers,  
the Danish enzyme company 
Novozymes and others to develop 
technologies that will revolutionize 
the ethanol industry,” says Muston.
Iowa currently has 28 ethanol 
plants producing about 1.8 billion 
gallons of  ethanol per year  
more than any other state. With 
construction of  Project Liberty, 
Iowa continues its leadership in 
renewable fuels, while setting the 
stage for greater—and greener—
accomplishments to come.   ■Broin's Project Liberty will create commercialization results 
that include 27 percent more ethanol from an acre of corn 
while using 83 percent less fossil fuels.
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E thanol, the clean-burning, high octane fuel distilled from Iowa’s corn fields, has the potential to free the U.S. from its foreign oil 
dependence. Transforming corn into 
ethanol, however, takes energy, usually  
in the form of  natural gas or coal.
Ames-based Frontline BioEnergy is de-
veloping biomass-to-energy conversion 
methods that reduce an ethanol plant’s 
consumption of  fossil fuels, making  
ethanol an even greener product.
As Iowa’s ethanol industry continues to 
grow, developing energy from biomass 
could result in huge savings for the 
state’s production facilities.
The Iowa Renewable Fuels Association 
says that at the end of  2006 Iowa had 
28 ethanol plants capable of  annually 
producing more than 1.8 billion gallons 
of  the corn based fuel as well as eight 
biodiesel facilities with an annual capac-
ity of  136 million gallons. Iowa ranks 
first in the nation in production capacity 
for both ethanol and biodiesel.
“Using biomass to fuel an ethanol plant 
can reduce costs in making ethanol. 
It also hedges against volatility in the 
natural gas market and doubles the 
renewable energy ratio of  the ethanol 
product,” says Jerod Smeenk, Frontline 
engineering manager. Smeenk says  
natural gas accounts for one third of   
the cost of  producing ethanol, the  
second-largest expense after corn.
The nine-employee Frontline moved to 
Ames from Colorado in late 2005 to be 
closer to producer customers for its new 
biomass technologies.
Assisting its move was a $60,000 award 
from the Value-Added Agricultural 
Products and Processes Financial  
Assistance Program (VAAPFAP),  
administered by the Iowa Department 
of  Economic Development.
The company is also working closely 
with Iowa State University to improve 
the design and operation of  gasifiers that 
could process more than 300 tons of  
biomass per day. Smeenk says that while 
the USDA estimates a potential annual 
supply of  1.4 billion tons of  biomass, 
there are challenges in using biomass  
as an energy source.
“There are the issues of  collection, 
transportation, storage and end process-
ing of  the biomass,” says Smeenk. “But 
every step we take in developing energy 
from biomass is another step away from 
our dependence on foreign and fossil 
energy sources.”   ■ 
On the Frontline of biomass energy 
Researcher Ted Heindel, at Iowa State 
University, is working with Frontline 
BioEnergy to commercialize gasifiers 
that convert biomass into a mixture 
of flammable gases. The resulting gas 
could be used to replace natural gas 
burned in ethanol plants. The project 
is partially supported by the 
Iowa Values Fund, Iowa’s premier 
economic development program.
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Revolution coming 
in biodiesel 
Victor Lin and a team of  Iowa State 
University researchers have found  
a better way to make biodiesel in  
a chemistry lab. Now they’re testing 
the tiny nanospheres they’ve  
developed on a bigger scale and  
looking toward establishing a  
company that would move the new 
technology into biorefineries. “This is 
a project that’s definitely relevant to 
the state’s economy,” Lin said.  
“I thought as a scientist I could  
contribute something to the state.” 
The project is supported by a grant 
from the Iowa Values Fund.   ■
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W hile nearly 80 percent of  Americans  favor increased use of  ethanol to ease our “addiction” to oil, there is still 
concern that ethanol’s demand for corn will create 
grain shortages that drive up the cost of  food. 
It is a question that once again will challenge  
the abilities of  agriculture to increase grain  
production in ways that are economically  
efficient and environmentally sustainable. 
Eighty years ago, the development of  hybrid  
corn sparked a revolution that allowed farm  
production to outpace rapidly growing global 
population. The question today is whether  
agriculture, with advanced seeds, new technologies 
and improved management practices, can meet 
its food and feed objectives and deliver a stable, 
sustainable fuel supply through ethanol, biodiesel 
and other biofuel production. 
There is no easy answer to the energy challenge, 
so it is important to see the whole picture, espe-
cially when food sources are being considered as 
fuel. Energy conservation and the development 
of  new energy sources must be fully researched. It 
also is essential to know what we can expect from 
agriculture, a sophisticated, research-based field 
that our non-agrarian society may not fully appre-
ciate. Many of  the top seed-industry players, for 
example, invest as much in research as a pharma-
ceutical company per dollar of  sales. Agricultural 
research, both public and private, has one primary 
goal — to increase productivity to meet growing 
demand. 
In the near future, new technologies will enable 
ethanol production from nearly any source of   
cellulose — including crops and crop residue, 
wood, grasses and even trash. Those advance-
ments will enable the biofuels industry to grow to 
a much larger scale. But for now, we are relying 
solely on crops such as sugar cane, soybeans and 
especially corn. 
To see where corn production can go, it is helpful 
to see how far it has come. In 1945, U.S. farmers 
harvested about 40 bushels of  grain per acre.  
Today, thanks to elite hybrids, new technologies 
and growers’ management practices, the U.S. 
average is 160 bushels per acre. Many growers 
consistently produce 250 bushels, up to a record 
of  400-plus bushels. 
The revolution in agricultural science and technol-
ogy over the past 80 years is no less phenomenal 
than other scientific fields that have taken us to 
unimagined places. As we grapple with how to 
secure a sustainable food and energy future, we 
should not underestimate the ability of  the world’s 
farmers — armed with cutting-edge science from 
both public and private institutions — to perform 
great things.   ■
